About this trial
this study aims to assess the short-term (3-month) clinical and echocardiographic outcomes of primary PCI among STEMI patients from rural versus urban areas in Upper Egypt. A special focus will be placed on identifying predictors of MACE. The findings may offer valuable insight into optimizing STEMI care pathways and support the development of regional STEMI networks across Egypt.
Eligibility criteria
Qualifiers
1. Adults aged ≥18 years. 2. Confirmed diagnosis of ST-segment elevation myocardial infarction (STEMI) based on ECG and cardiac biomarkers.
Disqualifiers
Non-STEMI or unstable angina cases.
Patients who received fibrinolytic therapy instead of PCI.
Transfer from another facility after more than 12 hours of symptom onset.
Patients with previous revascularization (e.g., CABG or PCI within the last 6 months).
Trial design
Treatments tested in this trial
- Primary Percutaneous Coronary Intervention (PPCI)